Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e42-e49. doi: 10.1097/MEG.0000000000002034.

Abstract

Liver dysfunction manifesting as elevated aminotransferase levels has been a common feature of coronavirus disease-2019 (COVID-19) infection. The mechanism of liver injury in COVID-19 infection is unclear. However, it has been hypothesized to be a result of direct cytopathic effects of the virus, immune dysfunction and cytokine storm-related multiorgan damage, hypoxia-reperfusion injury and idiosyncratic drug-induced liver injury due to medications used in the management of COVID-19. The favored hypothesis regarding the pathophysiology of liver injury in the setting of COVID-19 is cytokine storm, an aberrant and unabated inflammatory response leading to hyperproduction of cytokines. In the current review, we have summarized the potential pathophysiologic mechanisms of cytokine-induced liver injury based on the reported literature.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19* / complications
  • Cytokine Release Syndrome* / complications
  • Cytokine Release Syndrome* / virology
  • Cytokines
  • Humans
  • Liver Diseases / virology*

Substances

  • Cytokines